Our aforementioned data prompted us to examine whether inactivating SLC7A11 with sulfasalazine would potentiate metformin-induced lipid peroxidation and ferroptosis, thus sensitizing cancer cells to metformin. This evidence concerns the gene SLC7A11 and cancer.